Tag: life sciences
-
Boron Radiation Therapy Company Forms with $40M Funding
A start-up enterprise, spun off from a fusion energy company, plans to develop radiation therapies for solid tumor cancers often considered difficult to treat with conventional methods.
-
Trial Shows Patch Feasible for Heart Rhythm Detection
Results from a clinical trial show a wearable patch, applied and used by older adults in their homes, detects more heart rhythm problems than waiting to see a doctor, the usual way these problems are detected.
-
Smartphone App, Device Shown to Measure Blood Pressure
A smartphone-based system and app were shown in a pilot study with human subjects to measure a person’s blood pressure with about the same accuracy as some cuff devices normally used to gauge blood pressure.
-
Evotec Acquiring Sanofi Infectious Disease Portfolio
Drug discovery company Evotec AG is licensing 10 infectious disease R&D programs and their 100 employees from drug maker Sanofi, and opening new labs for this work in Lyon, France.
-
Peptide Hydrogel Boosts Cancer Immunotherapies
A team at Rice University in Houston developed an injectable gel material that in lab mice slows the release of cancer immunotherapy drugs, enhancing the treatments’ effectiveness and reducing the need for repeated doses.
-
Company Formed to Develop Cancer Cell Therapies
The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells.
-
FDA Clears Consumer Genetic Breast Cancer Risk Tests
The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer.
-
Institute, Company Studying Neuro Disease Proteins
The Montreal Neurological Institute and Thermo Fisher Scientific are beginning a study of 30 proteins implicated in neurodegenerative diseases to validate related antibodies and reagents for advancing treatments.
-
3-D Biomaterial Boosts Personal Cancer Immunotherapy
A Harvard University bioengineering lab developed an injectable material designed to load up with proteins from a patient’s own tumors to induce immune reactions that fight that person’s cancer.
-
Breathalyzer Biopsy Company Gains $15M in New Funds
A company in the U.K. developing a technology for early and precise diagnosis of lung and other cancers by analyzing exhaled breath is raising $15 million in new venture capital.